The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Current state of spinal muscular atrophy in Canada: Practical considerations for clinicians | Webinar report

In partnership with Muscular Dystrophy Canada (MDC), NMD4C delivered its first webinar on April 21, 2020. The topic was the current state of spinal muscular atrophy (SMA) in Canada, with a target audience of neurologists, scientists, physicians, medical trainees/students, and other allied healthcare professionals involved in the care of patients with neuromuscular disease (NMD). The goal was to share knowledge on best practices, current issues, disease diagnosis and management, and possible therapeutic interventions.


Read the webinar report HERE


Topics and speakers:

SMA Clinical Care in the Era of COVID-19

Dr. Jodi Warman Chardon (NMD4C Steering Committee member)

Newborn Screening in Ontario

Dr. Kristin Kernohan, Dr. Alex Mackenzie, Dr. Hugh McMillan (NMD4C Investigator)

Update on Zolgensma for Canada

Dr. Hugh McMillan (NMD4C Investigator)

Update on Risdiplam for Canada

Dr. Craig Campbell (NMD4C Investigator)

Adult Outcome Measures

Dr. Colleen O’Connell

Update on CNDR-SMA Project

Dr. Lawrence Korngut (NMD4C Investigator), Dr. Victoria Hodgkinson (NMD4C Collaborator)

Annotation 2020-05-20 103803

Read next...

CIHR logo

NMD4C members awarded CIHR grants for oculopharyngeal dystrophy, spinal muscular atrophy research

The NMD4C is happy to share that two project applications from NMD4C members on oculopharyngeal dystrophy (OPMD) and spinal muscular atrophy (SMA)  have been awarded Canadian Institute of Health Research (CIHR) research grants in their recent round of funding decisions!

1x1Fellowship teaser

MDC & NMD4C Fellowship Funding Awards Coming Soon

The NMD4C in partnership with Muscular Dystrophy Canada (MDC) are excited to share that we will be launching a competition later this year to award funding for two postdoctoral research and two clinical fellowships! 

2021-SMAAM-Graphic

August is SMA Awareness Month: See What’s Happening Around the Community

August is Spinal muscular atrophy (SMA) awareness month, and the NMD4C would like to take this time to recognize the work that our members and partners have contributed over the past year. While the network is involved in SMA-related activities year-round, August provides an opportunity to highlight this work and the impact it has on those affected by SMA.

Opportunity-uOttawaPhD

Research Opportunity: PhD in Translational Mitochondrial/Stem-Cell Research at the uOttawa Centre for Neuromuscular Disease

The NMD4C are excited to share a new research opportunity in Translational Mitochondrial/Stem-Cell Research at the uOttawa Centre for Neuromuscular Disease. The research team is looking for a talented PhD student who is interested in studying how impairments in mitochondrial dynamics and function alter the metabolic profile and maintenance of muscle stem cells in patients with rare mitochondrial and neuromuscular diseases.

EPIC_DM

Myotonic Dystrophy: EPIC Functions at The Ottawa Hospital

Inspired by a DM family from Ottawa, The Ottawa Hospital (TOH) medical information team has designed a new Best Practice Advisories (BPA) for their electronic health record system EPIC, to keep DM patients safe throughout the hospital. 

2x3ENMC

European Neuromuscular Centre Themed Workshops

The NMD4C is excited to share that the European Neuromuscular Centre (ENMC) has announced a new initiative: Themed Workshops! The call for organisers who would like to apply for an ENMC workshop on this theme is now open and will run until September 30, 2021.